MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
6.04
+0.03 (0.50%)
At close: Jan 21, 2025, 4:00 PM
6.05
+0.01 (0.16%)
After-hours: Jan 21, 2025, 6:51 PM EST
MannKind Employees
As of December 31, 2023, MannKind had 414 total employees, including 411 full-time and 3 part-time employees. The number of employees increased by 19 or 4.81% compared to the previous year.
Employees
414
Change (1Y)
19
Growth (1Y)
4.81%
Revenue / Employee
$645,411
Profits / Employee
$52,094
Market Cap
1.67B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MNKD News
- 15 days ago - MannKind Expands Executive Leadership Team - GlobeNewsWire
- 5 weeks ago - MannKind Corporation: A Speculative Buy On IPF And Diabetes Markets - Seeking Alpha
- 5 weeks ago - MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®) - GlobeNewsWire
- 5 weeks ago - CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India - GlobeNewsWire
- 2 months ago - MannKind Corporation (MNKD) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - MannKind to Present at 2024 UBS Healthcare Conference - GlobeNewsWire
- 2 months ago - MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases - GlobeNewsWire